Combined change notifications within one dossier
For changes within one dossier involving listings of a single risk class, multiple changes submitted together can be considered in one Change Notification application. Fees and assessment follow the highest change category in that application.
- Grouping depends on the applicable change categories; this fact does not establish the separate rules for multiple dossiers or different risk classes.
- A new Change Notification application cannot be submitted while any Change Notification or renewal application remains pending for the same product or marketing authorization certificate.
- Applies to registered medical devices and IVDs; not to an initial registration application still under consideration.
Effective from 2026-06-30
Combined-application scope independently reviewed against the original EFDA/GDL/098 Version 002. This rule gives no standalone fee amount or review duration.